Covered recipient · General Payments record
ALIZA BITTON BEN-ZACHARIA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$40,852.71
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,748.00 | 2 |
| Food and Beverage | $632.61 | 9 |
| Education | $64.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,248.00 | 1 |
| TG THERAPEUTICS, INC. | $500.00 | 1 |
| Biogen, Inc. | $260.33 | 4 |
| EMD Serono, Inc. | $173.62 | 4 |
| GENZYME CORPORATION | $133.05 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $129.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Biogen, Inc. | $73.19 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104871428 | CMS |
| Biogen, Inc. | $33.58 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104847486 | CMS |
| Biogen, Inc. | $125.65 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104824336 | CMS |
| Biogen, Inc. | $27.91 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104868004 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,248.00 | 12/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101245050 | CMS |
| EMD Serono, Inc. | $42.90 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120230704 | CMS |
| EMD Serono, Inc. | $54.22 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120244905 | CMS |
| EMD Serono, Inc. | $64.00 | 03/27/2024 | Education | Undisputed | 01/23/2026 | 1120214628 | CMS |
| EMD Serono, Inc. | $12.50 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120245677 | CMS |
| GENZYME CORPORATION | $133.05 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139727080 | CMS |
| Novartis Pharmaceuticals Corporation | $129.61 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086767515 | CMS |
| TG Therapeutics, Inc. | $500.00 | 12/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136880676 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.